Clinical Trials Browser

Has results × dacomitinib × Head & Neck × Clear all

NCT00768664 2021-02-09

Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer

Phase 2 Completed

69 enrolled 18 charts

Head and Neck Neoplasms, Recurrence